Bioequivalence Study of a Generic Enoxaparin Sodium to Clexane ® After Single Subcutaneous Dose in Healthy Human Subjects

Condition:   Healthy Interventions:   Drug: Enoxaparin Sodium (Venus Remedies Limited);   Drug: Enoxaparin Sodium (Sanofi) Sponsor:   Venus Remedies Limited Completed

Source: ClinicalTrials.gov - March 3, 2022 Category: Research Source Type: clinical trials